Search Results for "Urology"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Urology. Results 11 to 20 of 40 total matches.

Laparoscopic Cholecystectomy

   
The Medical Letter on Drugs and Therapeutics • Dec 28, 1990  (Issue 834)
currently used for laparoscopic cholecystectomy, which were designed for gynecological or urological ...
Unlike new drugs, new techniques for surgery do not need the approval of any government agency. Laparoscopic cholecystectomy, made possible by the development of miniaturized television cameras, is one such technique that has recently attracted widespread interest (LW Way, N Engl J Med, 323:1273, Nov 1, 1990; R Winslow, Wall St J, 216:1, Dec 10, 1990).
Med Lett Drugs Ther. 1990 Dec 28;32(834):115-6 |  Show IntroductionHide Introduction

Tolterodine--A New Drug for Overactive Bladder

   
The Medical Letter on Drugs and Therapeutics • Oct 23, 1998  (Issue 1038)
the number of micturitions per 24 hours by about 20% (RA Appell, Urology, 50:90, 1997). ADVERSE EFFECTS ...
Tolterodine tartrate (Detrol - Pharmacia & Upjohn) is a new muscarinic receptor antagonist now being widely promoted for treatment of urinary frequency, urgency and urge incontinence caused by bladder (detrusor) overactivity.
Med Lett Drugs Ther. 1998 Oct 23;40(1038):101-2 |  Show IntroductionHide Introduction

Shockwave Therapy for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Nov 27, 2023  (Issue 1690)
. The American Urological Association guidelines (last updated in 2018) for treatment of erectile dysfunction ...
Low-intensity extracorporeal shockwave therapy similar to that used to fragment kidney stones or gallstones is a new option for treatment of erectile dysfunction that is now being advertised extensively in the US. It has not been approved by the FDA for treatment of erectile dysfunction.
Med Lett Drugs Ther. 2023 Nov 27;65(1690):190-1   doi:10.58347/tml.2023.1690d |  Show IntroductionHide Introduction

Terazosin for Benign Prostatic Hyperplasia

   
The Medical Letter on Drugs and Therapeutics • Feb 18, 1994  (Issue 916)
, and some patients require a second operation (H Lepor, Urology, 42:483,1993). Finasteride (Proscar ...
Terazosin (Hytrin - Abbott), a postsynaptic alpha 1 -adrenoreceptor blocker previ-ously available for treatment of hypertension (Medical Letter, 29:113, 1987), has now been approved by the US Food and Drug Administration (FDA) for treatment of benign prostatic hyperplasia (BPH). Although not previously approved by the FDA, terazosin and other alpha-blockers such as prazosin (Minipress, and others) or doxazosin (Car-dura) have been used for this indication for many years.
Med Lett Drugs Ther. 1994 Feb 18;36(916):15-6 |  Show IntroductionHide Introduction

Yohimbine for Male Sexual Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Dec 23, 1994  (Issue 938)
, Urology, 41:343, 1993). DOSAGE AND COST — The package insert recommends taking one 5.4-mg tablet ...
Yohimbine hydrochloride, a presynaptic 2 -adrenergic receptor antagonist available by prescription in the USA (Yocon, Yohimex, and others), is advertised for treatment of impotence and has been used as an aphrodisiac. A pre-1938 drug, yohimbine has never been approved for marketing by the US Food and Drug Administration.
Med Lett Drugs Ther. 1994 Dec 23;36(938):115-6 |  Show IntroductionHide Introduction

A Prostatic Urethral Lift for Benign Prostatic Hyperplasia

   
The Medical Letter on Drugs and Therapeutics • Nov 11, 2013  (Issue 1429)
to benign prostatic hyperplasia. Urology 2012; 79:5. 7. HH Woo et al. Preservation of sexual function ...
The FDA has approved the use of a permanent prostatic urethral lift implant (UroLift – NeoTract) to relieve low or blocked urine flow in men ≥50 years old with benign prostatic hyperplasia (BPH).
Med Lett Drugs Ther. 2013 Nov 11;55(1429):91 |  Show IntroductionHide Introduction

The Prostatron: Microwaves for Benign Prostatic Hyperplasia

   
The Medical Letter on Drugs and Therapeutics • Jun 07, 1996  (Issue 976)
, Urology, 42:483, 1993). Finasteride (Proscar − Medical Letter, 34:83, 1992), which inhibits an enzyme ...
The Prostatron, a microwave device manufactured by EDAP Technomed in Cambridge, MA, has been approved by the US Food and Drug Administration for treating symptoms of benign prostatic hyperplasia (BPH).
Med Lett Drugs Ther. 1996 Jun 7;38(976):53-4 |  Show IntroductionHide Introduction

PC Spes

   
The Medical Letter on Drugs and Therapeutics • Feb 19, 2001  (Issue 1098)
) and has produced responses in men with hormone-resistant prostate cancer (DC Smith et al, Urology 1998; 52:257 ...
PC Spes, a dietary supplement sold for "prostate health", is being used increasingly to treat prostate cancer.
Med Lett Drugs Ther. 2001 Feb 19;43(1098):15-6 |  Show IntroductionHide Introduction

Drugs for Kidney Stones

   
The Medical Letter on Drugs and Therapeutics • Nov 29, 2010  (Issue 1352)
. Urology 2010; 75:4. 7. TA Abdel-Meguid et al. Tamsulosin to treat uncomplicated distal ureteral calculi ...
Renal colic is a common problem in emergency departments. Stones <5 mm in diameter often pass spontaneously; stones >10 mm in diameter generally do not. The usual treatment for stones that do not pass is ureteroscopy with laser lithotripsy or shockwave lithotripsy. Some clinicians have suggested that off-label use of an oral alpha-adrenergic blocker such as tamsulosin (Flomax, and others) or calcium channel blocker such as nifedipine (Procardia XL, and others) could be tried first, with or without a corticosteroid. Both adrenoreceptors and calcium channels may have a role in the...
Med Lett Drugs Ther. 2010 Nov 29;52(1352):93-4 |  Show IntroductionHide Introduction

Sildenafil: An Oral Drug for Impotence

   
The Medical Letter on Drugs and Therapeutics • May 08, 1998  (Issue 1026)
relaxes smooth muscle, allowing engorgement (TF Lue in PC Walsh et al, eds, Campbell’s Urology, 7th ed ...
Sildenafil citrate (Viagra - Pfizer) is the first oral drug approved by the FDA for treatment of erectile dysfunction. Alprostadil is also marketed for this indication but must be injected into the corpus cavemosum (Caverject) or pushed into the urethra (MUSE).
Med Lett Drugs Ther. 1998 May 8;40(1026):51-2 |  Show IntroductionHide Introduction